Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions in Obesity
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 08 Apr 2017
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 21 Mar 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 12 Sep 2016 Status changed from recruiting to active, no longer recruiting.